Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis

被引：0
|
作者：
Huihui Li
Fengli Hu
Yanli Zhang
Kai Li
机构：
[1] Heze Municipal Hospital,Department of Neurology
来源：
Journal of Neurology | 2020年 / 267卷
关键词：
Disease-modifying therapy; Relapsing–remitting multiple sclerosis; Systematic review; Network meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3489 / 3498
页数：9
相关论文
共 50 条
  • [1] Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis
    Li, Huihui
    Hu, Fengli
    Zhang, Yanli
    Li, Kai
    JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3489 - 3498
  • [2] Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis
    Fogarty, Emer
    Schmitz, Susanne
    Tubridy, Niall
    Walsh, Cathal
    Barry, Michael
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 23 - 30
  • [3] Comparative efficacy and safety of disease-modifying therapies in patients with relapsing multiple sclerosis: A systematic review and network meta-analysis
    Chen, Chaoyang
    Zhang, Enyao
    Zhu, Chunsu
    Wei, Ran
    Ma, Lingyun
    Dong, Xiu
    Li, Ruoming
    Sun, Feng
    Zhou, Ying
    Cui, Yimin
    Liu, Zhenming
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (01) : 8 - +
  • [4] Comparative safety of high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis
    Katarzyna Śladowska
    Paweł Kawalec
    Przemysław Holko
    Oktawia Osiecka
    Neurological Sciences, 2022, 43 (9) : 5479 - 5500
  • [5] Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: A Network Meta-Analysis
    Rosa C. Lucchetta
    Fernanda S. Tonin
    Helena H. L. Borba
    Letícia P. Leonart
    Vinicius L. Ferreira
    Aline F. Bonetti
    Bruno S. Riveros
    Jefferson Becker
    Roberto Pontarolo
    Fernando Fernandez-Llimós
    Astrid Wiens
    CNS Drugs, 2018, 32 : 813 - 826
  • [6] Comparative safety of high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis
    Sladowska, Katarzyna
    Kawalec, Pawel
    Holko, Przemyslaw
    Osiecka, Oktawia
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5479 - 5500
  • [7] Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis
    Lucchetta, Rosa C.
    Tonin, Fernanda S.
    Borba, Helena H. L.
    Leonart, Leticia P.
    Ferreira, Vinicius L.
    Bonetti, Aline F.
    Riveros, Bruno S.
    Becker, Jefferson
    Pontarolo, Roberto
    Fernandez-Llimos, Fernando
    Wiens, Astrid
    CNS DRUGS, 2018, 32 (09) : 813 - 826
  • [8] Impact of disease-modifying therapies on MRI outcomes in patients with relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis
    Bose, Debdipta
    Ravi, Renju
    Maurya, Miteshkumar
    Pushparajan, Libby
    Konwar, Mahanjit
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 61
  • [9] Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis
    Liu, Zhuoyi
    Liao, Qiao
    Wen, Haicheng
    Zhang, Yihao
    AUTOIMMUNITY REVIEWS, 2021, 20 (06)
  • [10] Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: A systematic comparison
    Freedman, Mark S.
    Hughes, Bruce
    Mikol, Daniel D.
    Bennett, Randy
    Cuffel, Brian
    Divan, Vamil
    LaVallee, Nicole
    Al-Sabbagh, Ahmad
    EUROPEAN NEUROLOGY, 2008, 60 (01) : 1 - 11
12345